Articles by Walter Armstrong - Pharmaceutical Executive

ADVERTISEMENT

Articles by Walter Armstrong

Diabetes: Agonists versus Inhibitors

Dec 1, 2010

Pharm Exec's Pipeline Report 2013

Lupus: How Big will Benlysta Become?

Dec 1, 2010

Pharm Exec's Pipeline Report 2022

Hyperlipidemia: The Anti-CETPs Redux

Dec 1, 2010

Pharm Exec's Pipeline Report 2011

Rheumatoid Arthritis: JAKing Down Inflammation

Dec 1, 2010

Pharm Exec's Pipeline Report 2023

Cancer: On Target Once More

Dec 1, 2010

Pharm Exec's Pipeline Report 2019

Acute Coronary Syndrome

Dec 1, 2010

Pharm Exec's Pipeline Report 2012

Nicotine Addiction: What Lights Up the Field

Dec 1, 2010

Pharm Exec's Pipeline Report 2018

Multiple Sclerosis: The Advent of the Orals

Dec 1, 2010

Pharm Exec's Pipeline Report 2021

Science and Politics at the FDA

Nov 1, 2010

Harvard professor Daniel Carpenter offers a piercing analysis of the FDA and sheds light on its biggest challenges

ADVERTISEMENT

Click here